Spallanzani Institute, Gamaleya Center to study efficacy of Sputnik V with various strains : vimarsana.com

Spallanzani Institute, Gamaleya Center to study efficacy of Sputnik V with various strains
Earlier, the Italian Spallanzani Institute and the Russian Gamaleya Center signed a memorandum on scientific cooperation
© Vyacheslav Prokofyev/TASS, file
MOSCOW, April 13. /TASS/. The Gamaleya National Research Center for Epidemiology and Microbiology will study efficacy of the Sputnik V vaccine against various coronavirus strains within the framework of cooperation with the Spallanzani National Institute for Infectious Diseases, Alexander Gintsburg, Director of the Center that developed the vaccine, told TASS on Tuesday.
"This institute [Spallanzani] probably has the most representative collection of various strains in Europe. We are ready, using an extended variant, their collection, to conduct tests of protective capabilities of Sputnik V on those strains that interest us and on those strains that are now relevant both for Italy and the EU," the scientist said.

Related Keywords

Italy , Moscow , Moskva , Russia , United Kingdom , Brazil , Italian , Russian , Brazilian , British , Alexander Gintsburg , Gamaleya National Research Center , Gamaleya Center , Russian Direct Investment Fund , Spallanzani National Institute For Infectious Diseases , Russian Healthcare Ministry , Gamaleya Institute , Spallanzani Institute , Russian Gamaleya Center , Italian Spallanzani Institute , Russian Embassy , Spallanzani National Institute , Infectious Diseases , இத்தாலி , மாஸ்கோ , மோசிக்குவா , ரஷ்யா , ஒன்றுபட்டது கிஂக்டம் , பிரேசில் , இத்தாலிய , ரஷ்ய , பிரேசிலியன் , பிரிட்டிஷ் , ரஷ்ய நேரடி முதலீடு நிதி , ரஷ்ய சுகாதாரம் அமைச்சகம் , ரஷ்ய தூதரகம் , தொற்று நோய்கள் ,